Has Ronald Morford, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,181 in general payments to Ronald Morford, MD across 123 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ronald Morford, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ronald Morford, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ronald Morford, MD

Interventional Cardiology · Lynchburg, VANPI 1518996347

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 66.4% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $1,078, more than ten times the $25 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in VA, where the typical reported total is $4,743.

$4,181in general payments, 2019–2025

Across 123 payments — averaging $33.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$3K
Medtronic$333
Penumbra, Inc.$308
Edwards Lifesciences$181
Cardiva Medical, Inc.$133
Cook Medical LLC$111
plus $337 from 7 others

$26,542in research payments, 2019–2025

Across 6 payments — averaging $4423.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bard Peripheral Vascular, Inc.$27K

What the payments were for

Food & beverage$4,181100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	88	$2,778
Medtronic(2 entities)	7	$333
Penumbra, Inc.	2	$308
Edwards Lifesciences	4	$181
Cardiva Medical, Inc.	4	$133
Cook Medical LLC	2	$111
Boston Scientific	5	$104
Biosense Webster, Inc.	3	$86
Abiomed	2	$45
Cardiovascular Systems Inc.	2	$42
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$40
Terumo Medical Corporation	1	$16
Reflow Medical Inc	1	$4

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,181 in reported general payments places this provider in the 45th percentile of 176 interventional cardiology providers in Virginia.

See all interventional cardiology providers in Virginia →

Medicare billing

Part B allowed, 2024

$124,530

Medicare patients

997

Services billed

1,444

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	78	$62,931
XareltoRivaroxaban	63	$54,561
EntrestoSacubitril/Valsartan	19	$20,826
Atorvastatin Calcium	89	$769
ClopidogrelClopidogrel Bisulfate	94	$586
Metoprolol Succinate	59	$553
Rosuvastatin Calcium	63	$503
Carvedilol	70	$469
Ezetimibe	32	$465
Famotidine	37	$392
Losartan Potassium	35	$372
Cilostazol	18	$352
Furosemide	93	$321
Warfarin Sodium	14	$298
Lisinopril	39	$296

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Lynchburg

Supawat RatanapoLynchburg$21K
Deepak TalrejaVirginia Beach$1.5M
Rajiv TayalFredericksburg$984K
Gansevoort DunningtonRichmond$440K
Matthew SummersNorfolk$308K
Noah JonesFalls Church$238K
Michael GenVirginia Beach$207K
Jeremy BockLeesburg$202K
Wayne BatchelorFalls Church$196K
Matthew SherwoodFalls Church$193K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →